Shares of IXICO plc (LON:IXI – Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 7.88 and traded as high as GBX 8.60. IXICO shares last traded at GBX 8.06, with a volume of 86,424 shares trading hands.
IXICO Stock Down 2.9%
The stock’s fifty day simple moving average is GBX 7.88 and its two-hundred day simple moving average is GBX 8.93. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The company has a market capitalization of £17.57 million, a price-to-earnings ratio of -4.13, a PEG ratio of -0.38 and a beta of 0.13.
IXICO (LON:IXI – Get Free Report) last posted its quarterly earnings results on Tuesday, May 19th. The company reported GBX (1.21) EPS for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The business had revenue of GBX 395 million during the quarter. On average, sell-side analysts predict that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Read More
- Five stocks we like better than IXICO
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
